Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations

Transplant Immunology

Volumn 5, Issue 3, 1997, Pages 204-211

  Qi, Zhongquan ^a   Riesbeck, Kristian ^a   Östraat, Öyvind ^a   Tufveson, Gunnar ^b   Ekberg, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OKT 4; OX 38; QUERCETIN; ROQUINIMEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CONFERENCE PAPER; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0030683573     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80039-1     Document Type: Conference Paper

References (44)

1. Cobbold SP, Adams E, Marshall SE, Davies JD, Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev. 149:1996;5.
2. Reinherz EL, Schlossman SF. The differentatiation and function of human T. Lymphocytes. Cell. 19:1980;821.
3. Hall BM. Cells mediating allograft rejection. Transplantation. 51:1991;1141.
4. Davis MM, Bjorkmann PJ. T cell antigen receptor genes and T cell recognition. Nature. 334:1988;395.
5. Chen Z, Cobbold S, Metcalfe S, Waldmann H. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur J. Immunol. 22:1992;805.
6. De Fazio SR, Masli S, Gozzo JJ. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells. Transplantation. 61:1996;104.
7. Shizuru JA, Seybel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats pretransplant anti-CD4 monclonal antibody therapy. Transplantation. 50:1990;366.
8. + T cell subsets in low and high-responder rat strains. J Immunol. 143:1989;2828.
9. Pearson TC, Bushell AR, Darby CR, West LJ, Wood KJ. Lymphocyte changes associated with prolongation of cardiac survival in adult mice using anti-CD4 monoclonal antibody. Clin Exp Immunol. 92:1993;211.
10. Burkhardt K, Charlton B, Mandel TE. An increase in the survivl of murine H-2 mismatched cultured foetal pancreas allografts using depleting or non-depleting anti-CD4 monoclonal antibodies and a further increase with the addition of cyclosporine. Transplantation. 47:1989;771.
11. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation. 61:1996;804.
12. +T cells. Transplantation. 54:1992;483.
13. Shizurn TA, Alters SE, Fathman CG. Anti-CD4 monoclonal antibodies in therapy creation of nonclassical tolerance in the adult. Immunol Rev. 129:1992;105.
14. + T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy. J. Rheumatol. 19:1992;1845.
15. Darby CR, Bushell A, Morris PT, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 bockade. Transplantation. 57:1994;1419.
16. Saitovitch D, Bushell A, Mabbs DW, Morris PT, Wood KJ. Kinetics of induction of transplantation tolerance with a nondepleting anti-CD4 monoclonal antibody and donor-specific transfusion before transplantation: A critical period of time is required for development of immunological unresponsiveness. Transplantation. 61:1996;1661.
17. Arima T, Lehmann M, Flye MW. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB%/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation. 63:1997;284.
18. Butcher GW, Howard JC. Genetic control of transplant rejection. Transplantation. 34:1982;161.
19. Stewart R, Butcher G, Herbert T, Roser B. Graft rejection in a congenic panel of rats with defined immune response genes for MHC class I I. Rejection of and priming to the RT1.Aa antigen. Transplantation. 40:1985;427.
20. Herbert T, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation. 46:1988;1288.
21. Lehmann M, Sternkopf F, Metz F, et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation. 54:1992;959.
22. Chace TH, Cowdery JS, Field EH. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J Immunol. 152:1994;405-412.
23. Olausson M, Arvidsson N, Lukes D, Qi Z, Ekberg H, Gannedahl G, Tufveson G. Impaired AT induced experimental transplantation tolerance with LS2616. Transplant Proc. 27:1995;3541.
24. Tufveson G, Gannedahl G, Johnsson C, Olausson M, Wanders A, Ekberg H. New immunosuppressants: testing and development in animal models and the clinical: with special reference to DSG. Immunol Rev. 130:1993;99.
25. Wanders A, Larsson E, Gerdin B, et al. Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new immuno-modulator LS-2616 (Linomide). Transplantation. 47:1989;216.
26. Wanders A, Vogt P, Karlsson-Parra A, Wonigkeit K, Gerdin B, Tufveson G. Evidence that LS-2616 (Linomide) causes acute rejection of rat allografts protected by cyclosporine but not of longterm suriviving allografts. Transplantation. 52:1991;234.
27. Östraat Ö, Qi Z, Olausson M, Tufveson G, Ekberg H. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation. Scand J Immunol. 45:1997;343.
28. Gannedahl G, Wanders A, Carlsson M, Tufveson G. 15-deoxyspergualin effects in rat heart allograft transplantation - relation to dose, timing, and cyclosporine. Transplantation. 55:1993;455.
29. Kalland T, Vogt P, Karlsson G, Stålhandske T. Augmentation of mouse natural killer cell activity by LS-2616 a new immunomodulator. J Immunol. 134:1985;3956.
30. Bengtsson M, Simonsson B, Carlsson K, et al. Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator linomide after autologous bone marrow transplantation. Transplantation. 53:1992;882.
31. Larsson EL, Toki A, Stålhandske T. Mechanism of action of the new immunomodulator LS-2616 on T cell responses. Int J Immunopharmacol. 9:1987;425.
32. Gonzalo TA, González-Garcia A, Kalland T, Hedlund G, Martinez AC, Kroemer G. Linomide inhibits programmed cell death in peripheral T cells in vivo. Eur J Immunol. 24:1994;48.
33. Olausson M, Mjörnstedt L, Lindholm L, et al. Non-suture organ grafting to the neck vessels in rats. Acta Chir Scand. 150:1984;463.
34. Roser BJ. Cellular mechanisms in neonatal and adult tolerance. Immunol Rev. 107:1989;179.
35. Jefferries WA, Green JR, William AF. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J. Exp Med. 162:1985;117.
36. Butcher GW, Corvalan JR, Licence DR, Howard JC. Immune response genes controlling responsiveness to major transplantation antigens; specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens. J. Exp Med. 155:1982;303.
37. McConnell BM. Comparison of CD4 and CD8 T cell reactivity in high-responder and low-responder strain combinations in the rat. Transplant Proc. 21:1989;3294.
38. Alfrey ET, Wang X, Lee L, et al. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents. Transplantation. 59:1995;1171.
39. Sriwatanawongsa V, Davies HS, Calne RY. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induce by liver grafting in rats. Nature Medicine. 1:1995;428.
40. Nuus S, Colon S, Smith C, Freed TH, Miles C, Freed TH, Miles C, Grey HM. Interaction between a 'processed' ovalbumin peptide and Ia molecules. Proc Natl Acad Sci USA. 83:1986;3968.
41. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Transplantation. 15:1994;32.
42. Sayegh MH, Sablinski T, Tanaka K, et al. Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allograft before and after engraftment. Transplantation. 51:1991;296.
43. Östraat Ö, Qi Z, Gannedahl G, Tufvesson G, Ekberg H. Moderate additive immunosuppressive effect of thalidomide combined with cyclosporine A in rat cardiac transplantation. Transplant Immunol. 4:1996;241.
44. Wang ZQ, Dudhane A, Orlikowsky T, Clarke K, Li X, Darzynkiewicz Z, Hoffmann MK. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol. 24:1994;1549.